trending Market Intelligence /marketintelligence/en/news-insights/trending/b3LnO6_hIO1L-uJ0RxMR9Q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Wound Management acquires remaining 50% stake in Cellerate

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Wound Management acquires remaining 50% stake in Cellerate

Wound Management Technologies Inc. closed the acquisition of the remaining 50% shares in Cellerate LLC from CGI Cellerate RX LLC, an affiliate of The Catalyst Group Inc., in exchange for 1,136,815 preferred shares.

Cellerate, which distributes two products for wound care, now operates as the wholly owned subsidiary of Wound Management, doing business as WNDM Medical.

Each series F preferred share of Wound Management issued for the transaction can be converted into 200 common shares of the company. The preferred shares will hold voting rights equal to the total number of common shares after conversion.

According to a March 21 filing by Wound Management, these preferred shares will have a higher priority than its common shares at the time of payment of dividends and distribution of assets. In case of liquidation, holders of the preferred share will get a preference of $5 apiece.

In line with the transaction, CGI founder and managing partner Ron Nixon was made the board member of Wound Management.

Fort Worth, Texas-based Wound Management develops, markets, and distributes wound care products based on collagen — a structural protein found in skin and other connective tissues.